Nina A. Cooperman

2 papers in the library · publishing 2019-2021

Papers

A Pilot Randomized Clinical Trial of Mindfulness-Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for People with Opioid Use Disorder and Chronic Pain: Impact on Illicit Drug Use, Health, and Well-Being

Journal of Substance Abuse Treatment May 8, 2021 Nina A. Cooperman, Adam W. Hanley, A. Kline et al.

Mindfulness-Oriented Recovery Enhancement (MORE) added to methadone maintenance treatment (MMT) reduced illicit drug use, craving, pain, physical and emotional limitations, depression, and anxiety, while increasing well-being, vitality, and social functioning through 16-week follow-up compared to MMT alone. In this randomized trial of 30 individuals in MMT, those receiving eight weekly two-hour MORE groups plus treatment as usual showed significantly better outcomes than those receiving only treatment as usual. The authors conclude that MORE could be an effective adjunct to MMT and that larger trials are warranted.

DOI: 10.1016/j.jsat.2021.108468 Full text Medicine Psychology

Mindfulness-oriented recovery enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial

Drug and Alcohol Dependence August 5, 2019 E. Garland, Adam W. Hanley, A. Kline et al.

Mindfulness-Oriented Recovery Enhancement (MORE) improved opioid craving, pain unpleasantness, stress, and positive affect more than treatment as usual among individuals with opioid use disorder and chronic pain receiving methadone maintenance therapy. Participants in MORE reported nearly 1.3 times greater self-control over craving. Positive affect was associated with reduced craving, and this link was significantly stronger for those in MORE. The findings suggest MORE may serve as a useful non-pharmacological adjunct for this population.

DOI: 10.1016/j.drugalcdep.2019.07.007 Full text Medicine Psychology